Product Images Irinotecan Hydrochloride

This is a medication called Irinotecan Hydrochloride, provided in a single-dose vial of 2mL. Each mL contains 20mg of the active ingredient. It must be diluted before intravenous use and is classified as a cytotoxic agent. The manufacturer is Fresenius Kabi. The lot number and expiration date are not specified in the text.*

This is a description of Hydrochloride Injection medication from Fresenius Kabi with a concentration of 40 mg per 2 mL (20 mg per mL), based on trihydrate, used for intravenous use. This medication contains 20 mg of Irinotecan, a cytotoxic agent. It must be diluted before use and kept at a controlled room temperature of 20 to 25°C (68° to 77°F). The medication is available in a container with a non-latex rubber closure. Additionally, the text includes several identification codes for the medication being described.*

This is a description for Irinotecan Hydrochloride Injection, a cytotoxic agent that should be diluted before intravenous use. It comes in a single-dose vial with a strength of 100 mg per 5 mL (20 mg per mL) and contains sorbitol and lactic acid. The usual dosage information can be found in the package insert, and it should be stored at 20-25°C and protected from freezing. The text also includes the NDC number and lot/exp information.*

This is a product description of an injection medication named Irinotecan Hydrochloride. The medication comes in the form of a sterile solution and is intended for intravenous use. It contains 20 mg of Irinotecan per mL, and each vial contains 100 mg of the medication in a 5 mL solution. The solution needs to be diluted before use and must be protected from light and freezing. The pH of the solution has been adjusted with sodium hydroxide or hydrochloric acid. The dosage information is mentioned in the package insert. The text also includes product identification numbers and some irrelevant characters.*